Aytu BioScience Inc. [NASDAQ: AYTU] surged by $0.1 during the normal trading session on Monday and reaching a high of $1.40 during the day while it closed the day at $1.39. The company report on August 17, 2020 that Aytu BioScience Announces Manufacture and Delivery of Healight(TM) Devices for Use in COVID-19 Clinical Study.
Delivery of Investigational Endotracheal Ultraviolet-A Light Catheter Devices Enables Near-Term Initiation of Planned Clinical Studies in Severely Ill COVID-19 Patients.
ENGLEWOOD, CO / ACCESSWIRE / August 17, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the “Company”) focused on commercializing novel products that address significant patient needs, today announced the delivery of Healight™ investigational devices. The delivery of these pilot scale Healight devices, designed and developed by Sterling Medical Devices (“Sterling”), enables the initiation of COVID-19 investigational clinical studies, which are expected to begin in the near-term.
Aytu BioScience Inc. stock has also gained 1.09% of its value over the past 7 days. However, AYTU stock has declined by -10.32% in the 3 months of the year. Over the past six months meanwhile, it has gained 76.02% and gained 42.93% year-on date.
The market cap for AYTU stock reached $167.12 million, with 120.62 million shares outstanding and 116.08 million shares in the current float. Compared to the average trading volume of 7.69M shares, AYTU reached a trading volume of 8338370 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Aytu BioScience Inc. [AYTU]:
H.C. Wainwright have made an estimate for Aytu BioScience Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 29, 2020.
The Average True Range (ATR) for Aytu BioScience Inc. is set at 0.07, with the Price to Sales ratio for AYTU stock in the period of the last 12 months amounting to 11.53. The Price to Book ratio for the last quarter was 0.57, with the Price to Cash per share for the same quarter was set at 0.52.
AYTU stock trade performance evaluation
Aytu BioScience Inc. [AYTU] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.09. With this latest performance, AYTU shares gained by 0.72% in over the last four-week period, additionally plugging by 76.02% over the last 6 months – not to mention a rise of 4.51% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AYTU stock in for the last two-week period is set at 50.89, with the RSI for the last a single of trading hit 55.12, and the three-weeks RSI is set at 49.73 for Aytu BioScience Inc. [AYTU]. The present Moving Average for the last 50 days of trading for this stock 1.4141, while it was recorded at 1.3180 for the last single week of trading, and 1.1869 for the last 200 days.
Aytu BioScience Inc. [AYTU]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Aytu BioScience Inc. [AYTU] shares currently have an operating margin of -222.35 and a Gross Margin at +40.74. Aytu BioScience Inc.’s Net Margin is presently recorded at -370.64.
Return on Total Capital for AYTU is now -158.70, given the latest momentum, and Return on Invested Capital for the company is -264.54. Return on Equity for this stock declined to -264.54, with Return on Assets sitting at -97.28.
Reflecting on the efficiency of the workforce at the company, Aytu BioScience Inc. [AYTU] managed to generate an average of -$511,923 per employee. Receivables Turnover for the company is 6.31 with a Total Asset Turnover recorded at a value of 0.26.Aytu BioScience Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.90 and a Current Ratio set at 2.00.
Earnings per share (EPS) analysis for Aytu BioScience Inc. [AYTU] stock
With the latest financial reports released by the company, Aytu BioScience Inc. posted -0.32/share EPS, while the average EPS was predicted by analysts to be reported at -0.33/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 3.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AYTU.
Aytu BioScience Inc. [AYTU]: Insider Ownership positions
There are presently around $12 million, or 7.60% of AYTU stock, in the hands of institutional investors. The top three institutional holders of AYTU stocks are: VANGUARD GROUP INC with ownership of 4,224,471, which is approximately 639.341% of the company’s market cap and around 9.70% of the total institutional ownership; BLACKROCK INC., holding 1,107,044 shares of the stock with an approximate value of $1.54 million in AYTU stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $0.49 million in AYTU stock with ownership of nearly 433.969% of the company’s market capitalization.
Positions in Aytu BioScience Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 58 institutional holders increased their position in Aytu BioScience Inc. [NASDAQ:AYTU] by around 7,542,157 shares. Additionally, 15 investors decreased positions by around 865,460 shares, while 9 investors held positions by with 282,807 shares. The mentioned changes placed institutional holdings at 8,690,424 shares, according to the latest SEC report filing. AYTU stock had 41 new institutional investments in for a total of 1,770,564 shares, while 9 institutional investors sold positions of 471,559 shares during the same period.